scorecardresearch
Add as a preferred source on Google
Sunday, February 22, 2026
TopicGlaxoSmithKline

Topic: GlaxoSmithKline

Blob that created history — tracking six-decade quest for respiratory syncytial virus vaccine

GlaxoSmithKline’s vaccine for respiratory syncytial virus was approved by The Medicines and Healthcare products Regulatory Agency in Britain on Monday.

WHO approves Glaxo and Eli Lilly drugs to treat Covid amid Omicron surge

Eli Lilly’s rheumatoid arthritis drug and GlaxoSmithKline's monoclonal antibody won the WHO nod.

GlaxoSmithKline, CureVac team up to develop vaccines to tackle Covid variants

The immunisations may be used to protect people who haven’t been inoculated or as booster shots if immunity from other vaccines wanes.

Sanofi and Glaxo start human trials for Covid-19 vaccine

The drugmakers, who have 11 trial sites across the US, aim to have results by December, allowing for the final phase of trials to begin.

Sanofi expects to get approval for its coronavirus vaccine in first half of 2021

Paris-based pharma giant Sanofi’s program with Britain's Glaxo is one of dozens sprinting to deliver a vaccine to help end the pandemic.

Unilever needs luck to gain energy from Horlicks deal in India

Horlicks is facing a challenge, even in India. The drink is losing its star status as the ‘healthy’ morning and after-school drink.

Glaxo to consider selling its stake in Indian consumer unit worth $3.1 bn

Revenue at GlaxoSmithKline's consumer unit in India has decreased in the last two years.  Its bestselling malted milk drink brand Horlicks will also be sold.

On Camera

Youth Congress, your foolish protest helped the Modi govt climb out of the AI summit hole

In tactical terms, the shirtless protest was worse than a self-goal. Suddenly, the fiascos of the AI Summit were forgotten, and the Youth Congress’s disruption became the issue.

In the West, there’s anxiety. In India, optimism—Rishi Sunak says India poised to be leader in AI

On Wednesday, the former UK Prime Minister Rishi Sunak was speaking in New Delhi at a Carnegie & Observer Research Foundation event on AI.

MoD, IAF agree on some exemptions to HAL for Tejas Mk1A, but no compromise on ‘must-have’ capabilities

IAF is fine with accepting the aircraft with 'must-haves', even if some other steps remain pending, which may take at least another year, it is learnt.

No country is ever fully sovereign. Cold War era taught India its real meaning

India’s fraught neighbourhood places multiple constraints on its strategic choices. It leaves no time to take a deep breath, lean back and reset.